End of Module

Submitted by: Submitted by

Views: 408

Words: 2731

Pages: 11

Category: Business and Industry

Date Submitted: 03/07/2013 06:52 AM

Report This Essay

End of Module Project

The context of the End of Module Project may be found in the case study - 'The global pharmaceutical industry: swallowing a bitter pill' (pages 547 - 556, set text).

Analyse the future strategic directions available for a specific pharmaceutical based organisation of your choice.  Identify the strategic options facing your chosen organisation and make recommendations as to the strategy you believe it should pursue, clearly explaining the rationale behind your recommendations.  You should pay particular attention to:

• the drivers towards globalisation within the pharmaceutical industry and the opportunities and threats involved therein

• the extent to which public opinion, legislators, regulators, lawyers and powerful public sector customers may influence the industry

Your final submission should be a written report of between 1500 - 2000 words

Name: Jamie Allen

Module: Business Strategy

Submission Date: 17th December 2012

Confidentiality: I have read, understand and adhere to the KOL Confidentiality Policy. Click here to access the KOL Confidentiality Policy.

Academic Integrity Statement: I have read and understood the Academic Integrity guidelines for Kaplan Open Learning and the University Of Essex, and declare that this assignment conforms to all of the rules and regulations contained therein.

Please note: the guidelines can be found in the Student Handbook (see section 6.4).

Assignment Checklist

Please make sure you have completed the below points before submitting you assignment:

• Spelling and grammar check

• Referencing completed

• Word count fulfilled

• Proof read completed

• All parts of the question answered

Introduction

The intent of this project is to analyse and recommend future strategic direction for the global pharmaceutical company, GlaxoSmithKline (GSK). Firstly, the history and current position of GSK shall be explored, including the drivers...